174 related articles for article (PubMed ID: 19126406)
1. Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
Biochem Biophys Res Commun; 2009 Feb; 379(3):785-9. PubMed ID: 19126406
[TBL] [Abstract][Full Text] [Related]
2. AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines.
Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
Anticancer Res; 2010 Jun; 30(6):2049-54. PubMed ID: 20651350
[TBL] [Abstract][Full Text] [Related]
3. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
[TBL] [Abstract][Full Text] [Related]
4. Phytoestrogens activate estrogen receptor beta1 and estrogenic responses in human breast and bone cancer cell lines.
Chrzan BG; Bradford PG
Mol Nutr Food Res; 2007 Feb; 51(2):171-7. PubMed ID: 17266178
[TBL] [Abstract][Full Text] [Related]
5. Progesterone induces BRCA1 mRNA decrease, cell cycle alterations and apoptosis in the MCF7 breast cancer cell line.
Ansquer Y; Legrand A; Bringuier AF; Vadrot N; Lardeux B; Mandelbrot L; Feldmann G
Anticancer Res; 2005; 25(1A):243-8. PubMed ID: 15816544
[TBL] [Abstract][Full Text] [Related]
6. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
Rajah TT; Du N; Drews N; Cohn R
Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
[TBL] [Abstract][Full Text] [Related]
7. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1.
Fan S; Yuan R; Ma YX; Meng Q; Goldberg ID; Rosen EM
Oncogene; 2001 Dec; 20(57):8215-35. PubMed ID: 11781837
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.
Elstrodt F; Hollestelle A; Nagel JH; Gorin M; Wasielewski M; van den Ouweland A; Merajver SD; Ethier SP; Schutte M
Cancer Res; 2006 Jan; 66(1):41-5. PubMed ID: 16397213
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA mutations and BRCA1 expression in breast cancer: potential biomarkers for chemoresistance.
Santarpia M; Altavilla G; Margeli M; Cirauqui B; Mesiti M; Cavallari V; Ramirez JL; Sanchez-Ronco M; Santarpia L; Taron M; Rosell R
Cancer Invest; 2008 Dec; 26(10):1044-51. PubMed ID: 18798071
[TBL] [Abstract][Full Text] [Related]
11. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional profiling of breast cancer cells exposed to soy phytoestrogens after BRCA1 knockdown with a whole human genome microarray approach.
Satih S; Chalabi N; Rabiau N; Bignon YJ; Bernard-Gallon DJ
Nutr Cancer; 2010; 62(5):659-67. PubMed ID: 20574927
[TBL] [Abstract][Full Text] [Related]
13. Prepubertal octylphenol exposure up-regulate BRCA1 expression, down-regulate ERalpha expression and reduce rat mammary tumorigenesis.
Peng JH; Zhang F; Zhang HX; Fan HY
Cancer Epidemiol; 2009 Jul; 33(1):51-5. PubMed ID: 19679048
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo.
Quaresima B; Romeo F; Faniello MC; Di Sanzo M; Liu CG; Lavecchia A; Taccioli C; Gaudio E; Baudi F; Trapasso F; Croce CM; Cuda G; Costanzo F
Clin Cancer Res; 2008 Nov; 14(21):6797-803. PubMed ID: 18980973
[TBL] [Abstract][Full Text] [Related]
15. Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe.
Tominaga Y; Wang A; Wang RH; Wang X; Cao L; Deng CX
Cell Death Differ; 2007 Mar; 14(3):472-9. PubMed ID: 17024228
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation.
Annab LA; Terry L; Cable PL; Brady J; Stampfer MR; Barrett JC; Afshari CA
Gynecol Oncol; 2000 Apr; 77(1):121-8. PubMed ID: 10739701
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
18. BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers.
Yuli C; Shao N; Rao R; Aysola P; Reddy V; Oprea-llies G; Lee L; Okoli J; Partridge E; Reddy ES; Rao VN
Oncogene; 2007 Sep; 26(41):6031-7. PubMed ID: 17384678
[TBL] [Abstract][Full Text] [Related]
19. Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligo microarray study.
Lavigne JA; Takahashi Y; Chandramouli GV; Liu H; Perkins SN; Hursting SD; Wang TT
Breast Cancer Res Treat; 2008 Jul; 110(1):85-98. PubMed ID: 17687646
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 accumulates in the nucleus in response to hypoxia and TRAIL and enhances TRAIL-induced apoptosis in breast cancer cells.
Fitzgerald LD; Bailey CK; Brandt SJ; Thompson ME
FEBS J; 2007 Oct; 274(19):5137-46. PubMed ID: 17803681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
